HCA Healthcare, Inc. $HCA Shares Sold by Arizona State Retirement System

Arizona State Retirement System lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 52,692 shares of the company’s stock after selling 1,290 shares during the quarter. Arizona State Retirement System’s holdings in HCA Healthcare were worth $22,457,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Chung Wu Investment Group LLC acquired a new position in HCA Healthcare during the 2nd quarter worth $27,000. Clearstead Trust LLC grew its position in shares of HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after buying an additional 53 shares in the last quarter. Ameriflex Group Inc. acquired a new stake in HCA Healthcare in the second quarter valued at approximately $27,000. Harbor Capital Advisors Inc. grew its holdings in HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after acquiring an additional 34 shares in the last quarter. Finally, Twin Peaks Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth $40,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 1.30% of the company’s stock.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Strong quarterly results and market reaction — HCA reported an EPS beat and raised FY 2026 guidance, prompting coverage noting a gap up in the stock after the print. Shares Gap Up on Strong Earnings
• Positive Sentiment: Analysts boost targets and maintain bullish ratings — Goldman Sachs raised its price target to $558 (buy) and Leerink Partners increased its target to $573 (outperform), supporting further upside potential. Goldman Sachs Raises PT Leerink Raises PT TickerReport
• Positive Sentiment: Additional bullish analyst commentary — Truist and Deutsche Bank analysts publicly stated expectations for HCA shares to rise, reinforcing the buy-side momentum. Truist Note Deutsche Bank Note
• Positive Sentiment: Brand and quality recognition — Multiple HCA hospitals placed on Healthgrades’ America’s 50/100/250 Best Hospitals lists, supporting reputation and referral flows. Healthgrades Recognition
• Positive Sentiment: Outpatient growth and M&A runway — Company commentary and industry pieces highlight HCA’s push into outpatient facilities and acquisition opportunities, which investors view as margin?accretive growth. Outpatient Growth Acquisition Opportunities
• Positive Sentiment: Bullish research notes/coverage — Zacks highlights HCA as a strong growth stock based on style scores, adding to favorable retail/institutional sentiment. Zacks Growth Stock Piece
• Neutral Sentiment: Analysts say the narrative is shifting — Coverage explores how the investment story is evolving post?earnings/target resets; watch valuation vs. growth expectations. Analyst Narrative
• Neutral Sentiment: Local expansion and competitive landscape — Reporting on new ER builds and regional facility activity (e.g., southwest Florida) that may influence local market share dynamics. Local ER Story Freestanding EDs
• Negative Sentiment: Policy/regulatory risk — HCA is publicly noting it is monitoring federal policy shifts that could affect reimbursement or operations; this is a watcher for downside risk. Policy Risk

Analysts Set New Price Targets

HCA has been the subject of several analyst reports. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday. Mizuho upped their price target on HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a report on Thursday, December 18th. Morgan Stanley cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a report on Monday, December 15th. Robert W. Baird upped their price objective on shares of HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Finally, Zacks Research downgraded HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Fifteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $518.76.

HCA Healthcare Trading Up 1.2%

Shares of HCA opened at $488.19 on Friday. The stock’s 50 day moving average is $481.07 and its two-hundred day moving average is $437.35. The firm has a market capitalization of $111.40 billion, a PE ratio of 17.20, a P/E/G ratio of 1.48 and a beta of 1.36. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $527.55.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. The company had revenue of $19.51 billion for the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business’s revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a $0.78 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.15%.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.